Coronavirus in Germany: fierce criticism of Donald Trump for wanting to remain exclusively with the vaccine

0
3


The Minister of Foreign Affairs of Germany, Heiko Maas, critical this Monday the alleged attempt by the President of the United States, Donald Trump, to get hold of exclusive rights to a vaccine against coronavirus in which the German biopharmaceutical company CureVac is working.

“German scientists are leaders in the development of medicines and vaccines in global cooperations. We cannot allow others to want to ensure the results of their investigations exclusively “Maas said in statements published by the media group Funke.

He added that He has already discussed this issue with his counterparts in Canada, South Korea, Brazil and Australia. and stressed that it is something that also will have to be addressed with the G7 states.

Look also

“We will only be able to fight this virus together and not against each other, he stressed.

After reports of Trump’s alleged attempt to buy the exclusive right to a potential coronavirus vaccine that appeared in the Sunday “Welt am Sonntag”, the company CureVac itself declined to comment on these speculations, although it denied “categorically” in a statement “the claims about the sale of the company or its technology”.

Heiko Maas strongly criticized Donald Trump for the rumors about the coronavirus vaccine. (AP)

Heiko Maas strongly criticized Donald Trump for the rumors about the coronavirus vaccine. (AP)

“CureVac AG, a biopharmaceutical company and pioneer in preclinical and clinical development of vaccines and therapeutic agents based on messenger RNA, confirms today that all internal efforts are dedicated to the development of a vaccine against the new coronavirus, with the aim of reaching help and protect people and patients around the world, “stresses the laboratory.

Look also

The statement adds that “with twenty years of experience and in-depth scientific knowledge,” CureVac is focused on developing a vaccine against the new coronavirus “effective, safe and quick to produce.”

An employee of the firm CureVac shows advances in the investigation to find the vaccine against the coronavirus (REUTERS / Andreas Gebert / file)

An employee of the firm CureVac shows advances in the investigation to find the vaccine against the coronavirus (REUTERS / Andreas Gebert / file)

The company, which has produced vaccines and therapeutic agents based on messenger RNA (ribonucleic acid) since 2006, also stated that it is working to expand its production capabilities in order to manufacture billions of individual doses if necessary of vaccines for pandemic situations such as COVID-19.

The company making the vaccine did not comment on Trump's attempt. (EFE)

The company making the vaccine did not comment on Trump’s attempt. (EFE)

German Interior Minister Horst Seehofer also spoke on Sunday at a press conference to reports on Trump’s alleged interest in acquiring the vaccine rights for the United States through high economic incentives and said that this matter would be a topic this Monday in the crisis cabinet.

Source: EFE

LEAVE A REPLY

Please enter your comment!
Please enter your name here